Filing Details
- Accession Number:
- 0000950170-24-105123
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-10 16:05:48
- Reporting Period:
- 2024-09-06
- Accepted Time:
- 2024-09-10 16:05:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1818794 | Dyne Therapeutics Inc. | DYN | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1789545 | William Richard Scalzo | 1560 Trapelo Road Waltham MA 02451 | Svp, Head Of Finance & Admin. | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-09-06 | 6,502 | $5.54 | 117,524 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-09-06 | 3,353 | $5.54 | 120,877 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-09-06 | 34,833 | $19.00 | 155,710 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-09-06 | 16,696 | $13.12 | 172,406 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-09-06 | 29,792 | $8.58 | 202,198 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-09-06 | 18,750 | $10.72 | 220,948 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-09-06 | 6,552 | $10.88 | 227,500 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-09-06 | 124,374 | $32.14 | 103,126 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-09-06 | 1,700 | $32.63 | 101,426 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock option (right to buy) | Disposition | 2024-09-06 | 6,502 | $0.00 | 6,502 | $5.54 |
| Common Stock | Stock option (right to buy) | Disposition | 2024-09-06 | 3,353 | $0.00 | 3,353 | $5.54 |
| Common Stock | Stock option (right to buy) | Disposition | 2024-09-06 | 34,833 | $0.00 | 34,833 | $19.00 |
| Common Stock | Stock option (right to buy) | Disposition | 2024-09-06 | 16,696 | $0.00 | 16,696 | $13.12 |
| Common Stock | Stock option (right to buy) | Disposition | 2024-09-06 | 29,792 | $0.00 | 29,792 | $8.58 |
| Common Stock | Stock option (right to buy) | Disposition | 2024-09-06 | 18,750 | $0.00 | 18,750 | $10.72 |
| Common Stock | Stock option (right to buy) | Disposition | 2024-09-06 | 6,552 | $0.00 | 6,552 | $10.88 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2030-07-30 | No | 4 | M | Direct | |
| 0 | 2030-07-30 | No | 4 | M | Direct | |
| 742 | 2030-09-15 | No | 4 | M | Direct | |
| 8,348 | 2031-12-09 | No | 4 | M | Direct | |
| 25,208 | 2032-07-10 | No | 4 | M | Direct | |
| 26,250 | 2032-12-08 | No | 4 | M | Direct | |
| 28,394 | 2033-11-14 | No | 4 | M | Direct |
Footnotes
- Includes 101,426 unvested RSUs.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $31.62 to $32.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4.
- The option was granted on July 31, 2020. The shares underlying the option vest over four years in equal quarterly installments through July 31, 2024, provided that no shares shall vest prior to December 2, 2020.
- The option was granted on July 31, 2020. The shares underlying the option vest over four years in equal quarterly installments through July 31, 2024, provided that no shares shall vest prior to December 2, 2020.
- The option was granted on September 16, 2020. The shares underlying the option vest over four years in equal monthly installments through September 16, 2024.
- The option was granted on December 10, 2021. The shares underlying the option vest over four years in equal monthly installments through December 10, 2025.
- The option was granted on July 11, 2022. The shares underlying the option vest over four years in equal monthly installments beginning on July 1, 2022.
- The option was granted on December 9, 2022. The shares underlying the option vest over four years in equal monthly installments through December 10, 2026.
- The option was granted on November 15, 2023. The shares underlying the option vest over four years in equal monthly installments through November 15, 2027.
Billionaire Hedge Funds
